Peripheral artery disease: potential role of ACE-inhibitor therapy

References

• AhimastosALawlerAReidC2006Ramipril markedly improves walking ability in patients with peripheral arterial diseaseAnn Intern Med144660416670135
   PubMed Web of Science ®Google Scholar
• AhimastosAADartAMLawlerA2008Reduced arterial stiffness may contribute to angiotensin-converting enzyme inhibitor induced improvements in walking time in peripheral arterial disease patientJ Hypertens2610374218398348
   PubMed Web of Science ®Google Scholar
• AntmanEMAnbeDTArmstrongPW2004ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction)Circulation110e82e29215339869
   PubMed Web of Science ®Google Scholar
• BelchJJTopolEJAgnelliG2003Prevention of Atherothrombotic Disease Network. Critical issues in peripheral arterial disease detection and management: a call to actionArch Intern Med1638849212719196
   PubMed Web of Science ®Google Scholar
• BhattDStegPOhmanE2006International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosisJAMA295180916403930
   PubMed Web of Science ®Google Scholar
• BrownNJVaughanDE1998Angiotensin-converting enzyme inhibitorsCirculation971411209577953
   PubMed Web of Science ®Google Scholar
• CannonRO1998Potential mechanisms for the effect of angiotensin-converting enzyme inhibitors on endothelial dysfunction: the role of nitric oxideAm J Cardiol828S10S9860347
   PubMed Web of Science ®Google Scholar
• ChobanianAVHaudenschildCCNickersonC1990Antiatherogenic effect of captopril in the Watanabe heritable hyperlipidemic rabbitHypertension15327312406202
   PubMed Web of Science ®Google Scholar
• ClementDLBoccalonHDormandyJ2000A clinical approach to the management of the patient with coronary (Co) and/or carotid (Ca) artery disease who presents with leg ischaemia (Lis)Int Angiol199712510905794
   PubMed Web of Science ®Google Scholar
• CoppolaGNovoS2007Statins and peripheral arterial disease: effects on claudication, disease progression, and prevention of cardiovascular eventsArch Med Res38479e48817560452
   PubMed Web of Science ®Google Scholar
• DietFPrattREBerryGJ1996Increased accumulation of tissue ACE in human atherosclerotic coronary artery diseaseCirculation942756678941100
   PubMed Web of Science ®Google Scholar
• DormandyJARutherfordRB2000Management of peripheral arterial disease (PAD). TransAtlantic Inter- Society Consensus (TASC)J Vasc Surg31S1eS29610666287
   PubMed Web of Science ®Google Scholar
• DzauVJReR1994Tissue angiotensin system in cardiovascular medicine: a paradigm shift?Circulation8949388281685
   PubMed Web of Science ®Google Scholar
• EnseleitFLüscherTFRuschitzkaF2003Angiotensin-converting enzyme inhibition and endothelial dysfunction: focus on ramiprilEur Heart J Suppl5Suppl AA31A36
   Web of Science ®Google Scholar
• FeringaHHvan WaningVHBaxJJ2006Cardioprotective medication is associated with improved survival in patients with peripheral arterial diseaseJ Am Coll Cardiol471182716545650
   PubMed Web of Science ®Google Scholar
• GalatiusSWroblewskiHSorensenV1999Reversal of peripheral microvascular dysfunction during long-term treatment with the angiotensin-converting enzyme inhibitor fosinopril in congestive heart failureJ Card Fail5172410194656
   PubMed Web of Science ®Google Scholar
• GibbonsGH1995Mechanisms of vascular remodeling in hypertension: role of autocrine-paracrine vasoactive factorsCurr Opin Nephrol Hypertens4189967541288
   PubMedGoogle Scholar
• GibbonsRJAbramsJChatterjeeK2003ACC/AHA 2002 guideline update for the management of patients with chronic stable angina – summary article: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on the Management of Patients With Chronic Stable Angina)J Am Coll Cardiol411596812570960
   PubMedGoogle Scholar
• GriendlingKKAlexanderRW1997Oxidative stress and cardiovascular diseaseCirculation96326459396412
   PubMed Web of Science ®Google Scholar
• HasdaiDGibbonsRJHolmesDRJr1997Coronary endothelial dysfunction in humans is associated with myocardial perfusion defectsCirculation96339059396432
   PubMed Web of Science ®Google Scholar
• HermannMLuscherTF2006Endothelial dysfunction: the crux of the cardiovascular disease continuumMedicographia2831825
   Google Scholar
• HigashiYSasakiSNakagawaK2000A comparison of angiotensin-converting enzyme inhibitors, calcium antagonists, beta-blockers and diuretic agents on reactive hyperemia in patients with essential hypertension: a multicenter studyJ Am Coll Cardiol352849110676671
   PubMed Web of Science ®Google Scholar
• HirschATHaskalZJHertzerNR2006ACC/AHA 2005 practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic)Circulation1131474547
   Web of Science ®Google Scholar
• LeeCMiuraKLiuX2000Biphasic regulation of leukocyte superoxide generation by nitric oxide and peroxynitriteJ Biol Chem275389657210976106
   PubMed Web of Science ®Google Scholar
• LonnEYusufSDzavikV2001Effects of ramipril and vitamin E on atherosclerosis: the Study to Evaluate Carotid Ultrasound Changes in Patients Treated With Ramipril and Vitamin E (SECURE)Circulation1039192511181464
   PubMed Web of Science ®Google Scholar
• LonnEMYusufSJhaP1994Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protectionCirculation902056697923694
   PubMed Web of Science ®Google Scholar
• ManciniGBHenryGCMacayaC1996Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) StudyCirculation94258658759064
   PubMed Web of Science ®Google Scholar
• McDermottMMKerwinDRLiuK2001Prevalence and significante of unrecognized lower extremity peripheral arterial disease in general medicine practiceJ Gen Intern Med163849011422635
   PubMed Web of Science ®Google Scholar
• MeredithITYeungACWeidingerFF1993Role of impaired endothelium-dependent vasodilation in ischemic manifestations of coronary artery diseaseCirculation87Suppl VV56V66
   Google Scholar
• MilioGCoppolaGGenova2004 Ischemia cronica critica e vascolopatia ischemica polidistrettuale. Atti del Congresso XXV Congresso Sezione Regionale Siciliana, Sciacca, 30 Sept – 2 Oct 2004.
   Google Scholar
• MünzelTKeaneyJF2001Are ACE inhibitors a “magic bullet” against oxidative stress?Circulation1041571411571254
   PubMed Web of Science ®Google Scholar
• NorgrenLHiattWRDormandyJA2007Management of peripheral arterial disease (PAD). TransAtlantic Inter-Society Consensus (TASC II)Int Angiol268115717489079
   PubMed Web of Science ®Google Scholar
• NovoSCoppolaG2002 The Cardiovascular Risk Burden of Peripheral Arterial Disease (PAD). Invited Reports from the 17th International Congress on Thrombosis, Monduzzi Editore S.p.A. e MEDIMOND Inc; CX26R9044:231e8.
   Google Scholar
• NovoSEvolaG2003Role of statins and angiotensin converting enzyme inhibitors (ACE-I) in the therapy peripheral arterial diseaseInt Angiol22Suppl 1e245e48
   Google Scholar
• NovoS1995The patient with intermittent claudicationEveryday problem in clinical cardiologyAmsterdamExcerpta Medica
   Google Scholar
• OstergrenJSleightbPDagenaiscG2004for the HOPE study investigators. Impact of ramipril in patients with evidence of clinical or subclinical peripheral arterial diseaseEur Heart J25172414683738
   PubMed Web of Science ®Google Scholar
• PaulMGantenD1992The molecular basis of cardiovascular hypertrophy: the role of the renin-angiotensin systemJ Cardiovasc Pharmacol19S5181381795
   PubMed Web of Science ®Google Scholar
• PepineCJ1998The effects of angiotensin-converting enzyme inhibition on endothelial dysfunction: potential role in myocardial ischemiaAm J Cardiol8223S7S9860352
   PubMed Web of Science ®Google Scholar
• PfefferMABraunwaldEMoyéLA1992on behalf of the SAVE Investigators. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the Survival and Ventricular Enlargement TrialN Engl J Med327669771386652
   PubMed Web of Science ®Google Scholar
• PfefferMALamasGAVaughanDE1988Effect of captopril on progressive ventricular dilation after anterior myocardial infarctionN Engl J Med3198062967917
   PubMed Web of Science ®Google Scholar
• RidkerPM1992An epidemiologic assessment of thrombotic risk factors for cardiovascular diseaseCurr Opin Lipidol3285290
   Google Scholar
• RollandPHCharpiotPFriggiA1993Effects of angiotensin-converting enzyme inhibition with perindolol on hemodynamics, arterial structure, and wall rheology in the hindquarters of atherosclerotic mini-pigsAm J Cardiol7122E27E
   PubMed Web of Science ®Google Scholar
• RomanoGCorradoEMuratoriI2006Carotid and peripheral atherosclerosis in patients who underwent primary percutaneous coronary intervention and outcome associated with multifocal atherosclerosisInt Angiol253899417164746
   PubMed Web of Science ®Google Scholar
• SchächingerVBrittenMBZeiherAM2000Prognostic impact of coronary vasodilator dysfunction on adverse long-term out come of coronary heart diseaseCirculation101189990610779454
   PubMed Web of Science ®Google Scholar
• SchiffrinEDengL1995Comparison of effects of angiotensin I-converting enzyme inhibition and b-blocade for two years on function of small arteries from hypertensive patientsHypertension256997037721419
   PubMed Web of Science ®Google Scholar
• SharpeNSmithHMurphyJ1991Early prevention of left ventricular dysfunction after myocardial infarction with angiotensin-converting-enzyme inhibitionLancet33787261672967
   PubMed Web of Science ®Google Scholar
• The Heart Outcomes Prevention Evaluation (HOPE) Study Investigators2000Effects of an angio tensin converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patientsN Engl J Med3421455310639539
   PubMed Web of Science ®Google Scholar
• The SOLVD Investigators1991Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failureN Engl J Med3252933022057034
   PubMed Web of Science ®Google Scholar
• VaughanD1997The renin-angiotensin system and fibrinolysisAm J Cardiol79Suppl 51269127616
   PubMedGoogle Scholar